Free tool
Rare disease stocks
We cover 9 companies grouped under the Rare disease theme. The median market value in the group is $830.56M. Across the group, the median move over the past trading day is −1.81%. Price change over the past year runs from −17.4% to +314.9% across the middle 80 percent of the group, with a median of +60.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
9 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 0L35.L | Sarepta Therapeutics, Inc. | $1.69B | Small cap | −0.06% | Nov 4, 2026 |
| 0LIF.L | Ultragenyx Pharmaceutical Inc. | $1.40B | Small cap | −13.39% | Nov 3, 2026 |
| 0HB0.L | Agios Pharmaceuticals, Inc. | $1.19B | Small cap | −13.00% | Oct 29, 2026 |
| DBV.PA | DBV Technologies S.A. | $901.25M | Small cap | +60.13% | Oct 28, 2026 |
| GNFT.PA | Genfit S.A. | $830.56M | Small cap | +310.45% | Sep 29, 2026 |
| 0KBU.L | Omeros Corporation | $575.28M | Small cap | +332.86% | Nov 12, 2026 |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% | Sep 29, 2026 |
| 0AB6.L | Hyloris Pharmaceuticals SA | $185.32M | Small cap | −33.23% | Sep 24, 2026 |
| 0H8T.L | Aclaris Therapeutics, Inc. | $122.82M | Small cap | +237.38% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.